Expression of Proteins Related Cell Cycle and Apoptosis during Diethylnitrosamine (DEN)-induced Hepatocarcinogenesis in Rats |
Sim, Woo-Jung
(Departments of Surgery, College of Medicine, Chung-Ang University)
Kim, Yong-Seok (Departments of Surgery, College of Medicine, Chung-Ang University) Choi, Yoo-Shin (Departments of Surgery, College of Medicine, Chung-Ang University) Kim, Beom-Gyu (Departments of Surgery, College of Medicine, Chung-Ang University) Cha, Seong-Jae (Departments of Surgery, College of Medicine, Chung-Ang University) Lim, Hyun-Muck (Departments of Surgery, College of Medicine, Chung-Ang University) Park, Eon-Sub (Departments of Pathology, College of Medicine, Chung-Ang University) |
1 | Kumar S. Interleukin-1-converting enzyme (ICE)-like protease in apoptosis. Trends Biochem Sci 1995;20:198-202. DOI |
2 | Tewari M, Quan LT, O`Rourke K, Desnoyers S, Zeng Z, Beidler DR, et al. Yama/CPP32beta, a mammalian homolog of CED-3, is a Crma-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995;81:801-9. DOI ScienceOn |
3 | Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002;21:2613-22. DOI ScienceOn |
4 | Kothakota S, Azuma T, Reinhard C, Kippel A, Tang J, Chu K, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997;278:294-8. DOI |
5 | Lane DP. Cancer. p53, guardian of genome. Nature 1992;358: 15-6. DOI ScienceOn |
6 | Sherr CJ. Cancer cell cycle. Science 1996;274:1672-7. DOI |
7 | Scherer E, Emmelot P. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumor formation by diethylnitrosamine in the rat. Eur J Cancer 1975;11:689-96. DOI |
8 | Sela B. Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence. Harefuah 2002;141: 103-7, 123. |
9 | Lloyd RV, Jin L, Qian X, Kulig E. Aberrenr p27kip1 expression in endocrine and other tumors. Am J Pathol 1997;150:401-7. |
10 | Grossman D, McNiff JM, Li F, Altieri DC. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 1999;113:1076-81. DOI |
11 | Cox LS. Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J Pathol 1997;183:134-40. DOI ScienceOn |
12 | Grasl-Kraupp B, Ruttkay-Nedecky B, Műllauer L, Taper H, Huber W, Bursch W, et al. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 1997;25:906-12. DOI ScienceOn |
13 | Wu MS, Shun CT, Sheu JC, Wang HP, Wang JT, Lee WJ, et al. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages. J Gastroenterol Hepatol 1998;13:305-10. DOI ScienceOn |
14 | Guo Y, Sklar GN, Borkowski A, Kyprianou N. Loss of the cyclin-dependent kinase inhibitor p27 (Kip1) protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 1997;3:2269-74. |
15 | Nishida N, Fukuda Y, Ishizaki K, Nakao K. Alteration of cell cycle-related genes in hepatocarcinogenesis. Histol Histopathol 1997;12:1019-25. |
16 | Meki AR, Abdel-Ghaffar SK, El-Gibaly I. Aflatoxin B1 induces apoptosis in rat liver: protective effect of melatonin. Neuro Endocrinol Lett 2001;22:417-26. |
17 | Miyagawa S, Okada N, Takasaki Y, Iida T, Kitano Y, Yoshigawa K, et al. Expression of proliferating cell nuclear antigen/cyclin in human keratinocytes. J Invest Dermatol 1989;93:678-81. DOI ScienceOn |
18 | Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80: 293-9. DOI ScienceOn |
19 | Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8. DOI |
20 | Maronpot RR, Montgomery CA Jr, Boorman GA, McConnell EE. National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol Pathol 1986;14:263-73. DOI ScienceOn |
21 | Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501. DOI ScienceOn |
22 | Li F, Ambrosini G, Chu EY, Plesicia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-4. DOI ScienceOn |
23 | Kamb A. Cell-cycle regulators and cancer. Trends Genet 1995;11:136-40. DOI ScienceOn |
24 | Pines J, Hunter T. Cyclins and cancer. II: cyclin D and cyclin dependant kinase inhibitors come of age. Cell 1994;79:573-82. DOI ScienceOn |
25 | Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 2000;31:1080-5. DOI ScienceOn |
26 | Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatus A, Nagata S. A caspase-activated deoxyribonuclease (DNase) that degrades DNA during apoptosis, and its inhibitor ICAD (inhibitor of caspase-activated deoxyribonuclease). Nature 1998;391:43-50. DOI ScienceOn |
27 | Cryns V, Yuan J. Proteases to die for. Genes Dev 1998;12: 1551-70. DOI ScienceOn |